Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management.

Mapel DW, Hurley JS, Dalal AA, Blanchette CM.

Prim Care Respir J. 2010 Jun;19(2):93-103. doi: 10.4104/pcrj.2010.00020. Review.

2.

Effective management of COPD in primary care - the role of long-acting beta agonist/inhaled corticosteroid combination therapy.

van Schayck CP, Reid J.

Prim Care Respir J. 2006 Jun;15(3):143-51. Epub 2006 Apr 11. Review.

3.

The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.

Hanania NA.

Pulm Pharmacol Ther. 2008;21(3):540-50. doi: 10.1016/j.pupt.2007.12.004. Epub 2008 Jan 6. Review.

PMID:
18280761
4.
5.

Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.

Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.

Ann Pharmacother. 2010 Apr;44(4):613-22. doi: 10.1345/aph.1M243. Epub 2010 Mar 16.

PMID:
20233915
6.
7.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
8.

Innovations to achieve excellence in COPD diagnosis and treatment in primary care.

Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.

Postgrad Med. 2010 Sep;122(5):150-64. doi: 10.3810/pgm.2010.09.2212. Review.

PMID:
20861599
9.

Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.

Blanchette CM, Culler SD, Ershoff D, Gutierrez B.

Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.

PMID:
20110003
10.

Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.

Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.

Arch Intern Med. 2009 Aug 10;169(15):1403-10. doi: 10.1001/archinternmed.2009.233. Erratum in: Arch Intern Med. 2009 Sep 28;169(17):1568.

PMID:
19667304
11.
12.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
13.

[Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].

Gillissen A, Gessner C, Hoheisel G, Juergens U.

Pneumologie. 2008 Jul;62(7):430-7. doi: 10.1055/s-2008-1038134. Epub 2008 Apr 9. Review. German.

PMID:
18398787
15.

[Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process].

Kardos P, Bechtel B, Palovis L, Hagedorn C, Latif F.

Pneumologie. 2012 Sep;66(9):549-57. doi: 10.1055/s-0032-1310076. Epub 2012 Aug 16.

16.
17.
18.

Inhaled corticosteroids in COPD: a controversy.

Barnes PJ.

Respiration. 2010;80(2):89-95. doi: 10.1159/000315416. Epub 2010 May 26. Review.

19.

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.

Ohar JA, Donohue JF.

Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Epub 2010 May 21. Review.

PMID:
20496301

Supplemental Content

Support Center